Bio-Ethics Drugs And Formulation Limited - Company Profile

It is a chemicals public limited company based in Cuttack, Orissa, India, established in 1995.

1995 Cuttack, Orissa, India Struck Off

Last Updated: July 23, 2025

About Bio-Ethics Drugs And Formulation Limited

Bio-Ethics Drugs And Formulation Limited, a struck off public limited company, was established on 16 March 1995 in Cuttack, Orissa, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231OR1995PLC003917. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

Its leadership includes Dhirendra Nath Dalai (Director). Its latest AGM occurred on 30 September 2008, with the balance sheet filed on 31 March 2008. It is based at Shreeram Bhawanmadhupatna Madhupatna, Cuttack, Orissa, 753010.

Company Details

CIN/LLPIN
U24231OR1995PLC003917
Registration Number
003917
Incorporation Date
16 March 1995
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Cuttack
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 1.00 M as on 23-07-2025
Paid Up Capital ₹ 0.50 M as on 23-07-2025
Company Age 30 Year, 11 Months
Last Filing with ROC 31 Mar 2008

Comprehensive Company Insights

Explore comprehensive insights into Bio-Ethics Drugs And Formulation Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Bio-Ethics Drugs And Formulation Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dhirendra Nath Dalai	Director	11 Feb 2003	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bio-Ethics Drugs And Formulation.

Enhance accessibility to Bio-Ethics Drugs And Formulation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bio-Ethics Drugs And Formulation?

Unlock access to Bio-Ethics Drugs And Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bio-Ethics Drugs And Formulation?

Unlock and access historical data on people associated with Bio-Ethics Drugs And Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bio-Ethics Drugs And Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Ethics Drugs And Formulation's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bio-Ethics Drugs And Formulation

Recent Activity within the Organization

Annual General Meeting

Progress on Bio-Ethics Drugs And Formulation Limited last Annual general meeting of members was held on 30 Sep 2008 as per latest MCA records. was documented.
30 Sep 2008
Balance Sheet

The activity Bio-Ethics Drugs And Formulation Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Cuttack. was completed.
31 Mar 2008
Director Appointment

The activity Dhirendra Nath Dalai was appointed as a Director was appointed as a Director on 11 Feb 2003 & has been associated with this company since 23 years 5 days . was completed.
11 Feb 2003
Company Incorporation

Progress on Bio-Ethics Drugs And Formulation Limited was registered on 16 Mar 1995 with Roc Cuttack & aged 30 years 11 months as per MCA records. was documented.
16 Mar 1995

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Bio-Ethics Drugs And Formulation Limited?

The CIN of Bio-Ethics Drugs And Formulation Limited is U24231OR1995PLC003917.

Where is Bio-Ethics Drugs And Formulation Limited headquartered?

Bio-Ethics Drugs And Formulation Limited is headquartered at Shreeram Bhawanmadhupatna Madhupatna, Cuttack, Orissa, 753010.

When was Bio-Ethics Drugs And Formulation Limited incorporated?

Bio-Ethics Drugs And Formulation Limited was incorporated on 16 March 1995.

Who are the current directors of Bio-Ethics Drugs And Formulation Limited?

The current directors of Bio-Ethics Drugs And Formulation Limited are

Dhirendra Nath Dalai

What is the primary industry of Bio-Ethics Drugs And Formulation Limited?

The primary industry of Bio-Ethics Drugs And Formulation Limited is Chemicals.

Is Bio-Ethics Drugs And Formulation Limited a listed company?

Bio-Ethics Drugs And Formulation Limited is unlisted.

What is the capital structure of Bio-Ethics Drugs And Formulation Limited?

The authorized capital of Bio-Ethics Drugs And Formulation Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available